Table 3

Characteristics of the 141 patients included in the study
P53 mutation MDM2 TT
No Yes No Yes
88 (62%) 53 (38%) 82 (58%) 59 (42%)
Age (years)
 ≤73 49 (64%) 27 (36%) 44 (58%) 32 (42%)
 >73 39 (60%) 26 (40%) 38 (58%) 27 (42%)
Gender
 Male 72 (62%) 44 (38%) 66 (57%) 50 (43%)
 Female 16 (64%) 9 (36%) 16 (64%) 9 (36%)
MDM2
 TT 38 (64%) 21 (36%) - -
 GG 11 (61%) 7 (39%) - -
 TG 39 (61%) 25 (39%) - -
p53 mutation
 Yes - - 32 (60%) 21 (40%)
 No - - 50 (57%) 38 (43%)
Recurrence
 Yes 75 (65%) 40 (35%) 66 (57%) 49 (43%)
 No 13 (50%) 13 (50%) 16 (62%) 10 (38%)
Progression
 Yes 30 (57%) 23 (43%) 27 (51%) 26 (49%)
 No 58 (66%) 30 (34%) 55 (62%) 33 (38%)

Olsson et al.

Olsson et al. BMC Urology 2013 13:5   doi:10.1186/1471-2490-13-5

Open Data